Tessa Therapeutics' Unattributed - II Round

Tessa Therapeutics raised a round of funding on April 12, 2018.

Tessa Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of cancer immunotherapies.…

Articles about Tessa Therapeutics' Unattributed - II Round: